10x Genomics logo
10x Genomics TXG
$ 16.78 2.76%

Quarterly report 2024-Q3
added 10-29-2024

report update icon

10x Genomics Balance Sheet 2011-2024 | TXG

Annual Balance Sheet 10x Genomics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-264 M -125 M -505 M -601 M -394 M -35.4 M -37.3 M - - - - - -

Long Term Debt

83.8 M 86.1 M 76.8 M 57 M 19.8 M 25.5 M 6.34 M - - - - - -

Long Term Debt Current

11.5 M 9.04 M 5.13 M 5.94 M 9.88 M - - - - - - - -

Total Non Current Liabilities

- - - - 123 M 312 M 166 M - - - - - -

Total Current Liabilities

127 M 131 M 110 M 118 M 63 M - - - - - - - -

Total Liabilities

224 M 223 M 201 M 190 M 186 M 344 M 188 M - - - - - -

Deferred Revenue

13.2 M 7.87 M 5.34 M 4.47 M 4.6 M 2.78 M 1.83 M - - - - - -

Retained Earnings

-1.28 B -1.03 B -863 M - -262 M -231 M -119 M - - - - - -

Total Assets

965 M 1.03 B 1.02 B 929 M 606 M 124 M 75.6 M - - - - - -

Cash and Cash Equivalents

359 M 220 M 587 M 664 M 424 M 65.1 M 47.9 M - - - - - -

Book Value

741 M 806 M 818 M 739 M 420 M -220 M -113 M - - - - - -

Total Shareholders Equity

741 M 806 M 818 M 739 M 420 M -220 M -113 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet 10x Genomics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

76.5 M 78.7 M 81 M - - 92.8 M 86.1 M - 91 M 93.5 M 76.8 M 75.7 M 65.9 M 66.3 M - - - - 19.8 M 19.8 M 19.8 M 19.8 M 25.5 M 25.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

215 M 206 M 204 M - - 212 M 223 M - 218 M 197 M 201 M 190 M 193 M 202 M 190 M 190 M 190 M 190 M 186 M 186 M 186 M 186 M 101 M 101 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

17.8 M 16.4 M 14.3 M - - 8.53 M 7.87 M - 6.47 M 5.43 M 5.34 M 5.5 M 5.27 M 4.48 M 4.47 M 4.47 M 4.47 M 4.47 M 3.3 M 3.3 M 3.3 M 3.3 M 2.4 M 2.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-1.42 B -1.38 B -1.34 B - - -1.08 B -1.03 B - -970 M -906 M -863 M -845 M -828 M -817 M -805 M -805 M -805 M -805 M -262 M -262 M -262 M -262 M -231 M -231 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

938 M 930 M 923 M - - 1.01 B 1.03 B - 1 B 1 B 1.02 B 991 M 978 M 954 M 929 M 929 M 929 M 929 M 606 M 606 M 606 M 606 M 124 M 124 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

398 M 380 M 356 M 315 M 331 M 340 M 227 M - 282 M 320 M 596 M 609 M 649 M 644 M 689 M 689 M 689 M 689 M 424 M 427 M 476 M 476 M 65.1 M 65.1 M - - 47.9 M - - - 41.7 M - - - - - - - - - - - - - - - - - - - - - - -

Book Value

723 M 724 M 719 M - - 802 M 806 M - 784 M 807 M 818 M 800 M 785 M 752 M 739 M 739 M 739 M 739 M 420 M 420 M 420 M 420 M 23.3 M 23.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

723 M 724 M 719 M 745 M 793 M 802 M 806 M - 784 M 807 M 818 M 800 M 785 M 752 M 739 M 739 M 739 M 739 M 420 M 420 M 420 M 420 M -220 M -220 M -132 M -127 M -113 M - - - -96.4 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency